Bernice R. Welles, MD, MBA
Vice President, Development

Dr. Welles was appointed Vice President, Development at DiObex in March 2005. Dr. Welles was most recently a Venture Partner at MPM Capital where she focused on evaluating potential investments with an emphasis on product candidates in discovery and development as well as to work closely with MPM’s portfolio companies to build their pipelines. Dr. Welles had previously spent 8 years at Genentech, Inc., where she ultimately served as Vice President of Product Development with responsibility for all development projects and portfolio planning. She was instrumental in the development and commercialization of several products, including Growth Hormone for Adult Growth Hormone Deficiency, Nutropin Depot, a long acting form of Genentech’s Growth Hormone, Raptiva for Psoriasis, and Lucentis, for Age-Related Macular Degeneration.

Dr. Welles is board certified in both Internal Medicine and in Endocrinology and Metabolism, having received an M.D. from Albany Medical College. She performed her residency training at Beth Israel Hospital in Boston and fellowship training at the University of California, San Francisco where she was the recipient of an NIH Clinical Investigator Development Award and where she stayed on as an Assistant Professor in the Department of Medicine prior to joining Genentech, Inc. Dr. Welles holds an MBA from the Wharton School at the University of Pennsylvania.